Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.1034
H.R.1034: Phair Pricing Act of 2019
About This Bill
- This bill was introduced in the 116th Congress
- This bill is primarily about health
- Introduced Feb. 7, 2019
- Latest Major Action Feb. 7, 2019
Bill Sponsor
Bill Cosponsors
77 (18 Democrats, 59 Republicans)
Bill Version
- Introduced in House - Feb. 7, 2019
Bill Summary
Phair Pricing Act of 2019 This bill requires that certain negotiated prices for covered drugs under the Medicare prescription drug benefit be disclosed at the point-of-sale. Specifically, negotiated prices offered under a prescription drug plan (PDP) must be disclosed at the point-of-sale; the disclosed price must include specified adjustments, payments, and fees that are negotiated with the pharmacy (e.g., dispensing fees) by the PDP sponsor...
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
Date | Description |
---|---|
Feb. 7, 2019 |
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
Feb. 7, 2019 |
Referred to the Subcommittee on Health.
|
Feb. 7, 2019 |
Introduced in the House by Doug Collins (R-Ga.) |